ClearPoint Neuro Inc (NASDAQ: CLPT) stock closed at $13.09 on 4/1/25 after a major increase of 10.1%. Moreover, above average trading volume at 132% of normal accompanied the advance. The stock has declined -5.0% during […]
Progress Software Corp (NASDAQ: PRGS) has reported E.P.S. of $0.25 for its first fiscal quarter (ending February 28) versus $0.52 for the same period a year ago — a decline of -52%. E.P.S. were $1.31 […]
On 3/31/25, bluebird bio Inc (NASDAQ: BLUE) stock enjoyed a major increase of 19.6%, closing at $4.88. Moreover, exceptionally high trading volume at 797% of normal accompanied the advance. The stock has been extremely weak […]
On 3/31/25, Corcept Therapeutics Inc (NASDAQ: CORT) stock enjoyed a major increase of 109.1%, closing at $114.22. Moreover, exceptionally high trading volume at 1069% of normal accompanied the advance. The stock has been exceptionally strong […]
HomeStreet Inc (NASDAQ: HMST) stock enjoyed a major increase of 26.2% on 3/31/25. The shares closed at $11.74. Moreover, this advance was accompanied by exceptionally high trading volume at 1383% of normal. Relative to the […]
Recent notable negative changes in fundamentals have affected Calumet Specialty Products Partn (NASDAQ: CLMT): the stock’s power rating fell below 50, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2026 decreased significantly. […]
On 3/31/25, UniQure NV (NASDAQ: QURE) stock suffered a major decline of -15.0%, closing at $10.60. Moreover, this decline was accompanied by exceptionally high trading volume at 379% of normal. The stock has been exceptionally […]
Recent meaningful negative changes in fundamentals have impacted Theravance Biopharma Inc (NASDAQ: TBPH): the stock’s power rating fell below 50, the consensus estimate for December, 2025 decreased significantly, and the consensus estimate for December, 2026 […]
FARO Technologies Inc (NASDAQ: FARO) suffers from exceptional negative changes in investment behavior: negative upside/downside volume developed, and its shorter term price trend turned down. Recent important negative changes in fundamentals have impacted FARO Technologies […]
On 3/31/25, Catalyst Biosciences Inc (NASDAQ: GYRE) stock suffered a major decline of -15.3%, closing at $7.72. Moreover, trading volume in this decline was exceptionally high at 326% of normal. Relative to the market the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research